FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Update on Software as a Medical Device Pilot

FDA posts an update on its ongoing pilot to develop a medical device software precertification program that notes FDA is leaning toward a question-bas...

Medical Devices

BD Alaris Pump Recall on Hardware Issues

Becton Dickinson CareFusion 303 recalls its Alaris System Infusion Pumps due to damaged inter-unit interface connectors, loose or missing battery scre...

Federal Register

Notice Correction on Pediatric Drug Safety Reviews

Federal Register notice: FDA corrects a 9/2 Federal Register notice that announced the availability of drug post-marketing pediatric-focused safety re...

Human Drugs

Guidance on Assessing Covid Symptoms in Clinical Trials

FDA releases a final guidance on Assessing Covid-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biolo...

Human Drugs

Guidance on Resuming Normal Drug/Biologic Manufacturing

FDA issues a temporary guidance entitled Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency to he...

Federal Register

Regulatory Review Period for Dyaxs Takhzyro

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Dyax Corp.s Takhzyro, indicated for prophylaxis...

Biologics

Covid-19 Vaccine Emergency Use Guide Soon: FDA

FDA says it will soon issue a guidance for sponsors to request an Emergency Use Authorization for their vaccines, including recommendations on the dat...

Human Drugs

Pharmacy Plus Warning on Unapproved Covid Products

FDA issues Pharmacy Plus (dba Vital Care Compounder) a Warning Letter for offering unapproved drug products for prophylaxis and treatment of, and reco...

Biologics

CBER Untitled Letter Over Unapproved Cellular Product

CBER sends an untitled letter to Laguna Beach Aesthetics, Cosmetic Dermatology and Laser Center over its unapproved cellular product derived from adip...

Human Drugs

RLC Labs Recalls Subpotent Thyroid Products

RLC Labs recalls 483 lots of Nature-Throid and WP Thyroid because FDA testing of samples from six lots found them to be subpotent.